Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
1
25%
Ph phase_4
2
50%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 42 (66.7%)

Trials by Status

recruiting125%
completed250%
not_yet_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingphase_4

Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children

NCT06929702
recruitingphase_4

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

NCT05548283
completed

Beta-lactam Pharmacokinetics in Secondary Care

NCT03033394
completedphase_2

Use of Probiotic Lactobacilli for the Treatment of Lactational Mastitis

NCT00716183

Clinical Trials (4)

Showing 4 of 4 trials
NCT06929702Phase 4

Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children

Not Yet Recruiting
NCT05548283Phase 4

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

Recruiting
NCT03033394

Beta-lactam Pharmacokinetics in Secondary Care

Completed
NCT00716183Phase 2

Use of Probiotic Lactobacilli for the Treatment of Lactational Mastitis

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4